Repligen Corporation
RGEN
$144.75
-$0.48-0.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 634.44M | 633.51M | 619.83M | 620.16M | 632.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 634.44M | 633.51M | 619.83M | 620.16M | 632.36M |
| Cost of Revenue | 315.77M | 308.99M | 315.02M | 317.52M | 323.54M |
| Gross Profit | 318.67M | 324.52M | 304.82M | 302.64M | 308.83M |
| SG&A Expenses | 238.28M | 257.55M | 237.93M | 221.70M | 216.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 596.79M | 607.82M | 595.05M | 580.75M | 583.03M |
| Operating Income | 37.65M | 25.69M | 24.78M | 39.41M | 49.33M |
| Income Before Tax | -27.04M | 13.44M | 25.97M | 41.85M | 56.71M |
| Income Tax Expenses | -1.52M | 21.53M | 16.49M | 18.29M | 21.11M |
| Earnings from Continuing Operations | -25.51 | -8.10 | 9.48 | 23.56 | 35.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.51M | -8.10M | 9.48M | 23.56M | 35.60M |
| EBIT | 37.65M | 25.69M | 24.78M | 39.41M | 49.33M |
| EBITDA | 107.30M | 94.24M | 91.93M | 105.69M | 114.07M |
| EPS Basic | -0.45 | -0.15 | 0.17 | 0.42 | 0.64 |
| Normalized Basic EPS | 0.51 | 0.45 | 0.44 | 0.63 | 0.80 |
| EPS Diluted | -0.46 | -0.15 | 0.16 | 0.41 | 0.63 |
| Normalized Diluted EPS | 0.51 | 0.45 | 0.44 | 0.62 | 0.78 |
| Average Basic Shares Outstanding | 223.74M | 223.50M | 223.26M | 223.08M | 222.88M |
| Average Diluted Shares Outstanding | 225.03M | 224.79M | 225.72M | 226.14M | 226.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |